LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 21.12

Change

0.00 (0.00)%

Market Cap

CAD 0.22B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.49 (-1.07%)

CAD 3.50B
ZWU:CA BMO Covered Call Utilities ETF

+0.08 (+0.74%)

CAD 1.80B
XIT:CA iShares S&P/TSX Capped Informa..

-0.87 (-1.21%)

CAD 0.89B
TXF:CA First Asset Tech Giants Covere..

-0.37 (-1.75%)

CAD 0.67B
HTA:CA Harvest Tech Achievers Growth ..

-0.19 (-1.04%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

+0.58 (+0.84%)

CAD 0.56B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.95 (+4.39%)

CAD 0.49B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.19 (+0.67%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.90 (+1.54%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.49 (+0.74%)

CAD 0.26B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.66% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.66% 100% F 90% A-
Trailing 12 Months  
Capital Gain -3.56% 26% F 16% F
Dividend Return 3.65% 63% D 58% F
Total Return 0.09% 20% F 16% F
Trailing 5 Years  
Capital Gain 2.97% 23% F 39% F
Dividend Return 36.35% 82% B 89% A-
Total Return 39.32% 31% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 0.69% 20% F 32% F
Dividend Return 1.89% 9% A- 29% F
Total Return 1.20% 53% F 44% F
Risk Return Profile  
Volatility (Standard Deviation) 6.98% 97% N/A 85% B
Risk Adjusted Return 27.06% 20% F 39% F
Market Capitalization 0.22B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.